StemBioSys Scientist shares her story with the Texas Public Radio audience

StemBioSys Scientist shares her story with the Texas Public Radio audience

StemBioSys Scientist, Anne Sheldrake, was invited to speak at Texas Public Radio’s first “Worth Repeating” event of their 5th season. She shared her story of confronting a mental health issue while pursuing a PhD. It is important to share these stories in the biosciences industry as graduate student mental health is too often ignored. Anne confronted and overcame an eating disorder, and for the last 2 years has been a key driver of innovation and new product development at StemBioSys. Anne, thank you for sharing your story.

Technical Bulletin: CELLvo™ Human Articular Chondrocytes Exhibit Native Chondrocyte Phenotype

Technical Bulletin: CELLvo™ Human Articular Chondrocytes Exhibit Native Chondrocyte Phenotype

CELLvo™ Matrix has recently been shown to improve the isolation and expansion of human chondrocytes, while minimizing significant change in phenotype [1]. Here, we compare gene expression of CELLvo™ Human Articular Chondrocytes (HC-A) to other commercially available articular chondrocyte products. Additionally, we examine the effect of culture on substrate choice (CELLvo™ Chondrocyte-Derived (CD) Matrix (in development) vs. tissue culture plastic (TCP)) on chondrocyte gene expression. We show that CELLvo™ HC-A are the only chondrocytes with a native phenotype, and that CELLvo™ CD Matrix minimizes loss of phenotype during in vitro expansion.